Many cancer patients show no symptoms at early stages and receive diagnoses at advanced stages, which can drastically attenuate treatment effectiveness and decrease their...
On the July 12, 2022, GenScript ProBio (Brian Ho-sung Min, CEO), a global CDMO, and ACT Therapeutics (Seogkyoung-Kong, CEO), developing next-generation chimeric antigen receptor...
Edison Partners, a leading growth equity firm, announced that it will exit portfolio company Budderfly, in which Partners Group acquired a majority stake. Upon...
The SEMI Foundation, the non-profit arm of SEMI, and the Council for Adult and Experiential Learning (CAEL), a nonprofit membership organization working to improve...
Enabling mutual customers to accelerate their development of advanced-node RF designs for 5G/6G applications, Synopsys announced it has developed an RF design reference flow...
